← Back to headlines
Amgen and AstraZeneca Launch Real-Time Drug Trials as FDA Expedites Development with AI
Pharmaceutical companies Amgen and AstraZeneca have begun real-time drug trials, coinciding with the FDA's use of artificial intelligence to speed up drug development.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
